(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:----------FTSE 100----------HSBC RAISES BERKELEY GROUP TO - PRICE - Read More
(Alliance News) - FTSE 100-listed medicine maker AstraZeneca PLC on Monday said its Imfinzi drug improved survival in advanced small cell lung cancer in a recent trial.In the phase 3 trial, Read More
(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:----------FTSE 100----------DEUTSCHE BANK CUTS LLOYDS Read More
(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:----------FTSE 100----------DEUTSCHE BANK RAISES BHP Read More
(Alliance News) - Pharmaceutical major AstraZeneca PLC on Wednesday said Tagrisso has been approved in China as a first-line treatment in advanced non-small cell lung cancer.Non-small cell Read More
(Alliance News) - The FTSE 100 rocketed higher on Monday, far outpacing the gains recorded elsewhere in Europe, as London's internationally-exposed index benefited from the pound's knocked Read More
(Alliance News) - The FTSE 100 index surged on Monday as the pound tumbled toward USD1.20 on a looming battle in Parliament over Brexit and some weak UK manufacturing data, leaving European equity Read More
(Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Monday.----------FTSE 100 - WINNERS----------AstraZeneca, a Read More
(Alliance News) - Stocks in London were higher early Monday but the pound continued to struggle amid the ongoing battle between UK Prime Minister Boris Johnson and his own Conservative party over Read More
(Alliance News) - AstraZeneca PLC on Monday reported positive study results for two separate treatments for prevention of cardiovascular events, particularly heart attacks in patients with or of Read More
(Alliance News) - Stocks in London were set for to open slightly higher Monday, after a slew of tariffs imposed by the US government on Chinese goods came into effect on Sunday but no new blow-ups Read More
(Alliance News) - Workers from some of the UK's biggest manufacturers have warned the Government that a no-deal Brexit would lead to a collapse in investment and could spark factory delegation Read More
(Alliance News) - AstraZeneca PLC on Thursday said its phase 3 Tulip 2 trial of potential new lupus drug anifrolumab met its primary endpoint.The trial assessed anifrolumab as a treatment 2 Read More
(Alliance News) - Stocks in London are set to open slightly lower on Thursday, easing after the boost given to the previous session by a weaker pound amid political crisis in the UK.In UK - Read More
(Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Wednesday.----------FTSE 100 - WINNERS----------BP, up Read More
(Alliance News) - AstraZeneca PLC on Wednesday posted positive results from its phase three trial of Breztri Aerosphere and said Fasenra has been granted orphan drug designation in the phase 3 of Read More
(Alliance News) - AstraZeneca PLC on Tuesday said the US has granted fast track designation for the development of Farixga as a treatment for renal failure in chronic kidney disease.The US Read More
(Alliance News) - AstraZeneca PLC announced Chinese approval for roxadustat in non-dialysis-dependent patients on Thursday, as well as the USD95 million purchase of a priority review voucher in Co Read More
(Alliance News) - UK Prime Minister Boris Johnson on Thursday is set for showdown Brexit talks in Paris, hours after French President Emmanuel Macron ruled out making concessions.The UK was Read More
(Alliance News) - Stocks in London are set to open lower on Thursday after minutes from the US Federal Reserve were less dovish than markets had been anticipating.In early UK company news, Read More